Literature DB >> 16814577

Stage-specific and differential notch dependency at the alphabeta and gammadelta T lineage bifurcation.

Maria Ciofani1, Gisèle C Knowles, David L Wiest, Harald von Boehmer, Juan Carlos Zúñiga-Pflücker.   

Abstract

Signals transduced by Notch receptors are indispensable for T cell specification and differentiation of alphabeta T lineage cells. However, the role of Notch signals during alphabeta versus gammadelta T lineage decision remains controversial. Here, we addressed this question by employing a clonal analysis of CD4(-)CD8(-) (DN) progenitor potential to position the divergence of alphabeta and gammadelta T cell lineages to the late DN2 to DN3 developmental stages. Accordingly, alphabeta and gammadelta precursor frequencies within these T cell progenitor subsets were determined, both in the presence and absence of Notch signaling through Delta-like 1. Notch signals were found to be critical for the DN to CD4(+)CD8(+) (DP) transition, irrespective of the identity (pTalphabeta or gammadelta) of the inducing T cell receptor complex, whereas gammadelta T cells developed from gammadeltaTCR-expressing T cell progenitors in the absence of further Notch ligand interaction. Collectively, our findings demonstrate a differential, stage-specific requirement for Notch receptor-ligand interactions in the differentiation of alphabeta and gammadelta T cells from T cell progenitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16814577     DOI: 10.1016/j.immuni.2006.05.010

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  88 in total

Review 1.  Disorderly conduct in gammadelta versus alphabeta T cell lineage commitment.

Authors:  Kavitha Narayan; Joonsoo Kang
Journal:  Semin Immunol       Date:  2010-05-06       Impact factor: 11.130

Review 2.  Determining γδ versus αß T cell development.

Authors:  Maria Ciofani; Juan Carlos Zúñiga-Pflücker
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

3.  Immature single-positive CD8+ thymocytes represent the transition from Notch-dependent to Notch-independent T-cell development.

Authors:  Juan Xiong; Michael A Armato; Thomas M Yankee
Journal:  Int Immunol       Date:  2010-12-09       Impact factor: 4.823

Review 4.  Decision checkpoints in the thymus.

Authors:  Andrea C Carpenter; Rémy Bosselut
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

Review 5.  Forging T-Lymphocyte Identity: Intersecting Networks of Transcriptional Control.

Authors:  Ellen V Rothenberg; Jonas Ungerbäck; Ameya Champhekar
Journal:  Adv Immunol       Date:  2015-10-26       Impact factor: 3.543

6.  Unexpected role for the B cell-specific Src family kinase B lymphoid kinase in the development of IL-17-producing γδ T cells.

Authors:  Renee M Laird; Karen Laky; Sandra M Hayes
Journal:  J Immunol       Date:  2010-10-25       Impact factor: 5.422

Review 7.  The Tec kinases Itk and Rlk regulate conventional versus innate T-cell development.

Authors:  Amanda L Prince; Catherine C Yin; Megan E Enos; Martin Felices; Leslie J Berg
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 8.  Gamma-delta T-cell lymphomas.

Authors:  Claudio Tripodo; Emilio Iannitto; Ada Maria Florena; Carlo Ennio Pucillo; Pier Paolo Piccaluga; Vito Franco; Stefano Aldo Pileri
Journal:  Nat Rev Clin Oncol       Date:  2009-11-10       Impact factor: 66.675

9.  Fli-1 regulates the DN2 to DN3 thymocyte transition and promotes γδ T-cell commitment by enhancing TCR signal strength.

Authors:  Monique F M A Smeets; David L Wiest; David J Izon
Journal:  Eur J Immunol       Date:  2014-07-24       Impact factor: 5.532

10.  Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A.

Authors:  Yumi Yashiro-Ohtani; Yiping He; Takuya Ohtani; Mary E Jones; Olga Shestova; Lanwei Xu; Terry C Fang; Mark Y Chiang; Andrew M Intlekofer; Stephen C Blacklow; Yuan Zhuang; Warren S Pear
Journal:  Genes Dev       Date:  2009-07-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.